Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Spark Therapeutics, Inc. (ONCE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/18/2019 |
3
| ROCHE HOLDINGS INC (10% Owner) has filed a Form 3 on Spark Therapeutics, Inc. |
| 12/17/2019 |
4
| Zoth Lota S. (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 3,000 shares
@ $114.5, valued at
$343.5k
Disposed/sold 4,000 options to buy
@ $81.53, valued at
$326.1k
Disposed/sold 4,000 options to buy
@ $50.93, valued at
$203.7k
Disposed/sold 6,000 options to buy
@ $56.22, valued at
$337.3k
Disposed/sold 12,000 options to buy
@ $37.18, valued at
$446.2k
|
|
| 12/17/2019 |
4
| Dalton Lisa (CHIEF HUMAN RESOURCE OFFICER) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 4,134 shares
@ $114.5, valued at
$473.3k
Disposed/sold 35,000 options to buy
@ $42.73, valued at
$1.5M
Disposed/sold 28,000 options to buy
@ $50.55, valued at
$1.4M
Disposed/sold 19,500 options to buy
@ $56.17, valued at
$1.1M
Disposed/sold 30,000 options to buy
@ $40.44, valued at
$1.2M
Disposed/sold 28,389 options to buy
@ $68.45, valued at
$1.9M
Disposed/sold 19,951 options to buy
@ $3.45, valued at
$68.8k
Disposed/sold 20,325 restricted stock units
@ $0 |
|
| 12/17/2019 |
4
| Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 6,102 shares
@ $114.5, valued at
$698.7k
Disposed/sold 35,000 options to buy
@ $42.73, valued at
$1.5M
Disposed/sold 28,000 options to buy
@ $50.55, valued at
$1.4M
Disposed/sold 25,000 options to buy
@ $56.17, valued at
$1.4M
Disposed/sold 55,000 options to buy
@ $40.44, valued at
$2.2M
Disposed/sold 60,000 options to buy
@ $68.45, valued at
$4.1M
Disposed/sold 106,015 options to buy
@ $3.45, valued at
$365.8k
Disposed/sold 19,500 restricted stock units
@ $0 |
|
| 12/17/2019 |
4
| SIGAL ELLIOT (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 14,214 shares
@ $114.5, valued at
$1.6M
Disposed/sold 4,000 options to buy
@ $81.53, valued at
$326.1k
Disposed/sold 4,000 options to buy
@ $50.93, valued at
$203.7k
Disposed/sold 6,000 options to buy
@ $56.22, valued at
$337.3k
Disposed/sold 17,203 options to buy
@ $3.45, valued at
$59.4k
Disposed/sold 25,786 options to buy
@ $3.45, valued at
$89k
|
|
| 12/17/2019 |
4
| PEREZ ROBERT J (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 2,500 shares
@ $114.5, valued at
$286.3k
Disposed/sold 4,000 options to buy
@ $81.53, valued at
$326.1k
Disposed/sold 8,000 options to buy
@ $55.76, valued at
$446.1k
Disposed/sold 2,000 restricted stock units
@ $0 |
|
| 12/17/2019 |
4
| MILANO VINCENT (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 3,000 shares
@ $114.5, valued at
$343.5k
Disposed/sold 4,000 options to buy
@ $81.53, valued at
$326.1k
Disposed/sold 4,000 options to buy
@ $50.93, valued at
$203.7k
Disposed/sold 6,000 options to buy
@ $56.22, valued at
$337.3k
Disposed/sold 37,203 options to buy
@ $3.45, valued at
$128.4k
|
|
| 12/17/2019 |
4
| Mehra Anand (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 40,203 shares
@ $114.5, valued at
$4.6M
Unknown transaction of 481,270 shares
@ $114.5, valued at
$55.1M
Disposed/sold 4,000 options to buy
@ $81.53, valued at
$326.1k
Disposed/sold 4,000 options to buy
@ $50.93, valued at
$203.7k
Disposed/sold 6,000 options to buy
@ $56.22, valued at
$337.3k
|
|
| 12/17/2019 |
4
| Mingozzi Federico (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 12,615 shares
@ $114.5, valued at
$1.4M
Disposed/sold 35,000 options to buy
@ $42.73, valued at
$1.5M
Disposed/sold 18,000 options to buy
@ $50.55, valued at
$909.9k
Disposed/sold 50,000 options to buy
@ $59.74, valued at
$3M
Disposed/sold 32,750 restricted stock units
@ $0 |
|
| 12/17/2019 |
4
| Marrazzo Jeffrey D (CEO) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 355,215 shares
@ $114.5, valued at
$40.7M
Disposed/sold 98,000 options to buy
@ $42.73, valued at
$4.2M
Disposed/sold 52,500 options to buy
@ $50.55, valued at
$2.7M
Disposed/sold 70,000 options to buy
@ $56.17, valued at
$3.9M
Disposed/sold 135,000 options to buy
@ $40.44, valued at
$5.5M
Disposed/sold 125,000 options to buy
@ $68.45, valued at
$8.6M
Disposed/sold 126,131 options to buy
@ $3.45, valued at
$435.2k
Disposed/sold 49,250 restricted stock units
@ $0 |
|
| 12/17/2019 |
4
| High Katherine A (See Remarks) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 278,834 shares
@ $114.5, valued at
$31.9M
Disposed/sold 35,000 options to buy
@ $42.73, valued at
$1.5M
Disposed/sold 23,625 options to buy
@ $50.55, valued at
$1.2M
Disposed/sold 15,750 options to buy
@ $56.17, valued at
$884.7k
Disposed/sold 13,750 options to buy
@ $40.44, valued at
$556.1k
Disposed/sold 21,250 restricted stock units
@ $0 |
|
| 12/17/2019 |
4
| Faga Daniel (Chief Business Officer) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 38,828 shares
@ $114.5, valued at
$4.4M
Disposed/sold 35,000 options to buy
@ $42.73, valued at
$1.5M
Disposed/sold 26,250 options to buy
@ $50.55, valued at
$1.3M
Disposed/sold 14,000 options to buy
@ $56.17, valued at
$786.4k
Disposed/sold 50,000 options to buy
@ $37.62, valued at
$1.9M
Disposed/sold 21,500 restricted stock units
@ $0 |
|
| 12/17/2019 |
4
| Ekman Lars (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 3,000 shares
@ $114.5, valued at
$343.5k
Disposed/sold 4,000 options to buy
@ $81.53, valued at
$326.1k
Disposed/sold 4,000 options to buy
@ $50.93, valued at
$203.7k
Disposed/sold 6,000 options to buy
@ $56.22, valued at
$337.3k
Disposed/sold 37,203 options to buy
@ $3.45, valued at
$128.4k
|
|
| 12/17/2019 |
4
| Altschuler Steven (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 28,000 shares
@ $114.5, valued at
$3.2M
Disposed/sold 4,000 options to buy
@ $81.53, valued at
$326.1k
Disposed/sold 4,000 options to buy
@ $50.93, valued at
$203.7k
Disposed/sold 6,000 options to buy
@ $56.22, valued at
$337.3k
Disposed/sold 37,203 options to buy
@ $3.45, valued at
$128.4k
|
|
| 12/17/2019 |
4
| La Barge Joseph (CHIEF LEGAL OFFICER) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 50,193 shares
@ $114.5, valued at
$5.7M
Unknown transaction of 200 shares
@ $114.5, valued at
$22.9k
Disposed/sold 35,000 options to buy
@ $42.73, valued at
$1.5M
Disposed/sold 21,000 options to buy
@ $50.55, valued at
$1.1M
Disposed/sold 12,500 options to buy
@ $56.17, valued at
$702.1k
Disposed/sold 11,250 options to buy
@ $40.44, valued at
$455k
Disposed/sold 19,500 restricted stock units
@ $0 |
|
| 06/27/2019 |
4
| Mingozzi Federico (Chief Scientific Officer) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,775 shares
@ $102.31, valued at
$283.9k
Exercised 8,375 restricted stock units
@ $0 |
|
| 06/03/2019 |
4
| Mehra Anand (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Exercised 1,500 restricted stock units
@ $0 |
|
| 06/03/2019 |
4
| Zoth Lota S. (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Exercised 1,500 restricted stock units
@ $0 |
|
| 06/03/2019 |
4
| SIGAL ELLIOT (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Exercised 1,500 restricted stock units
@ $0 |
|
| 06/03/2019 |
4
| PEREZ ROBERT J (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Exercised 1,500 restricted stock units
@ $0 |
|
| 06/03/2019 |
4
| MILANO VINCENT (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Exercised 1,500 restricted stock units
@ $0 |
|
| 06/03/2019 |
4
| Ekman Lars (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Exercised 1,500 restricted stock units
@ $0 |
|
| 06/03/2019 |
4
| Altschuler Steven (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Exercised 1,500 restricted stock units
@ $0 |
|
| 03/27/2019 |
4
| La Barge Joseph (Chief Legal Officer) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 31,389 shares
@ $113.42, valued at
$3.6M
Paid exercise price by delivering 21,260 shares
@ $113.38, valued at
$2.4M
Paid exercise price by delivering 8,873 shares
@ $113.36, valued at
$1M
Paid exercise price by delivering 4,770 shares
@ $113.36, valued at
$540.7k
Exercised 41,755 options to buy
@ $68.45, valued at
$2.9M
Exercised 33,748 options to buy
@ $40.44, valued at
$1.4M
Exercised 12,500 options to buy
@ $56.17, valued at
$702.1k
Exercised 7,000 options to buy
@ $50.55, valued at
$353.9k
|
|
| 03/27/2019 |
4
| Faga Daniel (Chief Business Officer) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 51,401 shares
@ $113.42, valued at
$5.8M
Paid exercise price by delivering 10,325 shares
@ $113.43, valued at
$1.2M
Paid exercise price by delivering 6,228 shares
@ $113.43, valued at
$706.4k
Exercised 80,000 options to buy
@ $37.62, valued at
$3M
Exercised 14,000 options to buy
@ $56.17, valued at
$786.4k
Exercised 8,750 options to buy
@ $50.55, valued at
$442.3k
|
|
| 03/25/2019 |
4
| High Katherine A (See Remarks) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 31,653 shares
@ $113.25, valued at
$3.6M
Paid exercise price by delivering 49,561 shares
@ $113.255, valued at
$5.6M
Paid exercise price by delivering 25,993 shares
@ $113.26, valued at
$2.9M
Paid exercise price by delivering 11,184 shares
@ $113.26, valued at
$1.3M
Paid exercise price by delivering 5,367 shares
@ $113.26, valued at
$607.9k
Exercised 73,249 options to buy
@ $3.45, valued at
$252.7k
Exercised 5,840 options to buy
@ $68.45, valued at
$399.7k
Exercised 3 options to buy
@ $40.44, valued at
$121.3
Exercised 64,160 options to buy
@ $68.45, valued at
$4.4M
Exercised 41,247 options to buy
@ $40.44, valued at
$1.7M
Exercised 15,750 options to buy
@ $56.17, valued at
$884.7k
|
|
| 03/21/2019 |
4
| La Barge Joseph (Chief Legal Officer) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Exercised 629 options to buy
@ $3.45, valued at
$2.2k
Exercised 8,683 options to buy
@ $3.45, valued at
$30k
Exercised 3,245 options to buy
@ $68.45, valued at
$222.1k
Exercised 2 options to buy
@ $40.44, valued at
$80.9 |
|
| 03/19/2019 |
4
| Marrazzo Jeffrey D (CEO) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Exercised 49,940 options to buy
@ $3.45, valued at
$172.3k
|
|
| 03/01/2019 |
4
| Children's Hospital of Philadelphia Foundation (10% Owner) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Sold 2,000,000 shares
@ $113, valued at
$226M
|
|
| 01/23/2019 |
4
| Mingozzi Federico (Chief Scientific Officer) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,627 shares
@ $87.98, valued at
$231.1k
Paid exercise price by delivering 733 shares
@ $45.08, valued at
$33k
Exercised 8,375 restricted stock units
@ $0
Exercised 2,000 restricted stock units
@ $0 |
|
| 01/23/2019 |
4
| Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 634 shares
@ $45.08, valued at
$28.6k
Paid exercise price by delivering 629 shares
@ $45.08, valued at
$28.4k
Exercised 1,750 restricted stock units
@ $0
Exercised 2,000 restricted stock units
@ $0 |
|
| 01/23/2019 |
4
| Marrazzo Jeffrey D (CEO) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,655 shares
@ $45.08, valued at
$74.6k
Paid exercise price by delivering 1,174 shares
@ $45.08, valued at
$52.9k
Exercised 5,000 restricted stock units
@ $0
Exercised 3,750 restricted stock units
@ $0 |
|
| 01/23/2019 |
4
| Dalton Lisa (Chief Human Resource Officer) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 792 shares
@ $45.08, valued at
$35.7k
Paid exercise price by delivering 621 shares
@ $45.08, valued at
$28k
Exercised 2,162 restricted stock units
@ $0
Exercised 2,000 restricted stock units
@ $0 |
|
| 01/23/2019 |
4
| High Katherine A (See Remarks) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 808 shares
@ $45.08, valued at
$36.4k
Paid exercise price by delivering 683 shares
@ $45.08, valued at
$30.8k
Exercised 2,250 restricted stock units
@ $0 |
|
|
|
|